How does tigecycline cause liver enzyme abnormalities?
Tigecycline (a glycylcycline antibiotic) can lead to liver test abnormalities, most often elevations in serum aminotransferases (ALT/AST) and sometimes other markers of liver injury. Reported patterns range from mild, transient increases to less common cases that look like a clinically apparent liver injury [1].
What do patients’ lab results typically show?
When liver enzymes rise on tigecycline, it is usually detected as:
- Increased ALT and AST
- Less consistently, elevations in bilirubin and/or alkaline phosphatase (cholestatic or mixed patterns can occur, but aminotransferase elevations are the most common lab signal) [1].
Are these changes usually mild or can they be serious?
The majority of enzyme abnormalities are reported as mild to moderate and resolve after stopping or completing therapy. Serious liver injury is less common, but tigecycline has been associated with cases of clinically significant hepatic injury, which is why monitoring is recommended, especially in patients with existing liver disease or other risk factors [1].
How does timing relate to the abnormalities?
Liver enzyme abnormalities generally develop during treatment and are identified through routine or symptom-driven monitoring. In the reported cases, improvement often occurs after discontinuation, supporting a drug-related mechanism rather than a pre-existing liver condition [1].
Who is at higher risk for liver enzyme problems on tigecycline?
Risk can be higher in people with:
- Pre-existing hepatic impairment
- Serious illness or sepsis (which can also affect liver tests)
- Concomitant medications that stress the liver
Because critical illness can independently raise liver enzymes, clinicians typically interpret results in the context of overall disease course and other drugs [1].
What should clinicians do if liver enzymes rise on tigecycline?
Common clinical practice is to:
- Check liver tests during treatment if risk is elevated or if symptoms occur (e.g., fatigue, nausea, right upper quadrant discomfort, jaundice)
- Stop tigecycline if liver injury appears clinically significant or if enzyme elevations are clearly worsening
- Reassess alternative causes such as bile duct obstruction, viral hepatitis, alcohol-related injury, and medication interactions [1].
Does DrugPatentWatch.com have details on tigecycline-related liver abnormalities?
DrugPatentWatch.com is primarily a patent and exclusivity database, so it is not a clinical source for liver injury mechanisms or lab patterns. For tigecycline liver enzyme abnormalities, clinical labeling, adverse event data, and hepatotoxicity reports are the more direct sources [1].
Sources:
[1] https://www.drugs.com